✦ LIBER ✦

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

✍ Scribed by Timothy S Maughan; Richard A Adams; Christopher G Smith; Angela M Meade; Matthew T Seymour; Richard H Wilson; Shelley Idziaszczyk; Rebecca Harris; David Fisher; Sarah L Kenny; Edward Kay; Jenna K Mitchell; Ayman Madi; Bharat Jasani; Michelle D James; John Bridgewater; M John Kennedy; Bart Claes; Diether Lambrechts; Richard Kaplan; Jeremy P Cheadle

Book ID: 117308483
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 364 KB
Volume: 377
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(11)60613-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent versus continuous oxaliplat

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

✍ Richard A Adams; Angela M Meade; Matthew T Seymour; Richard H Wilson; Ayman Madi 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 420 KB

6LBA Addition of cetuximab to oxaliplati

6LBA Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)

✍ T. Maughan; R.A. Adams; C.G. Smith; M.T. Seymour; R. Wilson; A.M. Meade; D. Fish 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

6006 ORAL Intermittent Chemotherapy (CT)

6006 ORAL Intermittent Chemotherapy (CT) Plus Continuous or Intermittent Cetuximab (C) in the First-line Treatment of Advanced Colorectal Cancer (aCRC): Results of the Two-arm Phase II Randomised MRC COIN-B Trial

✍ Wasan, H.; Adams, R.A.; Wilson, R.H.; Pugh, C.A.; Fisher, D.; Madi, A.; Sizer, B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Intermittent chemotherapy plus either in

Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

✍ Wasan, Harpreet; Meade, Angela M; Adams, Richard; Wilson, Richard; Pugh, Cheryl; 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 442 KB

Addition of cetuximab to chemotherapy as

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials

✍ Carsten Bokemeyer; Eric Van Cutsem; Philippe Rougier; Fortunato Ciardiello; Stef 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Sequential versus combination chemothera

Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial

✍ Michel Ducreux; David Malka; Jean Mendiboure; Pierre-Luc Etienne; Patrick Texere 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 331 KB